The KaraMINDS website is best viewed in landscape mode when viewed on a tablet. Please turn your device 90° for optimised viewing.
If viewing on a desktop, please increase the width of your browser window.
“The human mind is our fundamental resource.”
We know that the mind and the processes involved in maintaining it, are complex. Finding solutions for those in need and generations to follow, involves many minds.
The initial establishment of KaRa Minds has come about through the vision, commitment and compassion of two like-minded people who bring together two unique perspectives, encompassing pure and applied clinical research as well as care. KaRa Minds is an independent research institute based in Sydney, focus on the prevention, detection and cure of neurological diseases.
KaRa Mind is dedicated to preserving and achieving optimum mind health for all.
Our mission is to facilitate high calibre clinical trials for those areas that need exploration, supporting researchers which will ultimately translate discovery into improved diagnostics and better care.
We aim to bring together like-minded investigators, to promote biomedical and clinical research and undertake high impact studies. KaRa Minds promotes growth and advancement of knowledge within an atmosphere of genuine collaboration. KaRa Minds is about finding solutions to those questions that remain unanswered.
KaRa Minds is currently affiliated with and supported by the following people and organisations:
Mr Robin Freeman, ARV
Prof Lars Ittner, UNSW
Prof Michael Kassiou, U.Syd
Prof Roger Chung, Macquarie Uni
Dr Pon Anura, MMI
Anglican Retirement Villages (ARV)
McCusker Alzheimer’s Research Foundation
Edith Cowan University
A/Prof. Nat Lenzo, OMI
Mr Martin Pengilly
Mr Michael Apthorpe
A/Prof. Kathryn Goozee has over 30 years of clinical experience encompassing management, education and care. Within the last decade she has broadened her focus to encompass applied clinical research with a particular focus on Alzheimer’s disease prevention. Kathryn is co-founder of the KaRa Institute of Neurological Disease (KaRa Minds), and provides direct clinical governance and support across the team.
Professor Ralph Martins is well-known and highly respected both nationally and internationally as a leading researcher in Alzheimer’s Disease (AD). Over the last 30 years, his insight into this devastating disease has led to a number of ground breaking discoveries. He contributed to the pioneering discovery of Beta-amyloid (Aβ) and the amyloid precursor protein (APP), an important protein found in the brains of Alzheimer’s patients now universally acknowledged as being fundamental to the pathology of AD.